← Leaderboards
Nancy Joan Brown
Vanderbilt University
$32,445,188
Attributed
$36,171,722
Total exposure
49
Grants
31
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$41,137,453 · 50
By mechanism
R01$22,268,735 · 8
K12$11,145,834 · 3
P01$4,965,731 · 1
P20$1,270,094 · 1
P30$775,416 · 1
M01$711,643 · 36
Top collaborators
- Lynne W. Stevenson6 shared
- James Matthew Luther4 shared
- Anthony O Caggiano2 shared
- Talat Alp Ikizler2 shared
- Douglas B Sawyer2 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- James Matthew Luther$4,313,122
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchBradykininHuman SubjectHypertensionFibrinolysisPreventResearch PersonnelAngiotensin-Converting Enzyme InhibitorsAngiotensin IiAldosteroneDiabetes MellitusRenin Angiotensin SystemPeptidyl-Dipeptidase AAffectGrantLeadAfrican AmericanPharmaceutical PreparationsInhibitor/AntagonistReceptorResourcesEnzyme InhibitionRacial /Ethnic DifferenceResponse
Grant awards (148)
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition$478,331
R01 · FY2024 · HL · contact PI
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition$485,666
R01 · FY2023 · HL · contact PI
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition$492,044
R01 · FY2022 · HL · contact PI
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition$218,837
R01 · FY2022 · HL
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition$710,881
R01 · FY2021 · HL
Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity$467,438
R01 · FY2021 · DK
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition$710,881
R01 · FY2020 · HL
Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity$467,438
R01 · FY2020 · DK
Cardiovascular Consequences of Peptidase Inhibition$486,491
R01 · FY2019 · HL · contact PI
Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity$467,438
R01 · FY2019 · DK
Cardiovascular Consequences of Peptidase Inhibition$486,491
R01 · FY2018 · HL · contact PI
Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity$467,438
R01 · FY2018 · DK
Cardiovascular Consequences of Peptidase Inhibition$463,423
R01 · FY2017 · HL · contact PI
Cardiovascular Consequences of Peptidase Inhibition$431,108
R01 · FY2016 · HL · contact PI
Cardiovascular Consequences of Peptidase Inhibition$13,012
R01 · FY2016 · HL · contact PI
Cardiovascular Consequences of Peptidase Inhibition$444,120
R01 · FY2015 · HL · contact PI
Role of Eicosanoids in Renal Function$201,839
P01 · FY2015 · DK · contact PI
Renin-Angiotensin & Fibrinolysis Interaction in Humans$413,553
R01 · FY2014 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$259,426
R01 · FY2014 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$5,439
R01 · FY2014 · HL · contact PI
Role of Eicosanoids in Renal Function$1,376,598
P01 · FY2013 · DK · contact PI
Renin-Angiotensin and Fibrinolysis Interaction in Humans$408,110
R01 · FY2013 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$257,297
R01 · FY2013 · HL · contact PI
Role of Eicosanoids in Renal Function$154,364
P01 · FY2013 · DK · contact PI
Role of Eicosanoids in Renal Function$1,605,048
P01 · FY2012 · DK · contact PI
Renin-Angiotensin and Fibrinolysis Interaction in Humans$428,771
R01 · FY2012 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$308,880
R01 · FY2012 · HL · contact PI
Role of Eicosanoids in Renal Function$1,627,882
P01 · FY2011 · DK · contact PI
Vanderbilt Environmental Health Science Scholars Program$752,306
K12 · FY2011 · ES · contact PI
Recombinant Neuregulin for the treatment of Heart Failure$596,673
P20 · FY2011 · HL
Building Interdisciplinary Research Careers in Women's Health$484,025
K12 · FY2011 · HD · contact PI
Renin-Angiotensin and Fibrinolysis Interaction in Humans$421,538
R01 · FY2011 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$390,000
R01 · FY2011 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$44,175
R01 · FY2011 · HL · contact PI
Recombinant Neuregulin for the treatment of Heart Failure$673,421
P20 · FY2010 · HL
Vanderbilt Environmental Health Science Scholars Program$597,359
K12 · FY2010 · ES · contact PI
Building Interdisciplinary Research Careers in Women's Health$482,259
K12 · FY2010 · HD · contact PI
Vanderbilt Personalized Medicine Core$387,916
P30 · FY2010 · GM · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$387,500
R01 · FY2010 · HL · contact PI
Vanderbilt Environmental Health Science Scholars Program$951,925
K12 · FY2009 · ES · contact PI
RAAS, Inflammation & Post-Operative Atrial Fibrillation$606,277
R01 · FY2009 · HL · contact PI
Building Interdisciplinary Research Careers in Women's Health$480,545
K12 · FY2009 · HD · contact PI
Renin-Angiotensin and Fibrinolysis Interaction in Humans$438,135
R01 · FY2009 · HL · contact PI
Genes and Fibrinolytic Capacity of Human Endothelium$410,170
R01 · FY2009 · HL · contact PI
Vanderbilt Personalized Medicine Core$387,500
P30 · FY2009 · GM · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$298,426
R01 · FY2009 · HL · contact PI
Vanderbilt Environmental Health Science Scholars Program$717,105
K12 · FY2008 · ES · contact PI
RAAS, Inflammation & Post-Operative Atrial Fibrillation$579,385
R01 · FY2008 · HL · contact PI
Building Interdisciplinary Research Careers in Women's Health$478,882
K12 · FY2008 · HD · contact PI
Renin-Angiotensin and Fibrinolysis Interaction in Humans$424,714
R01 · FY2008 · HL · contact PI
Genes and Fibrinolytic Capacity of Human Endothelium$383,047
R01 · FY2008 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$298,426
R01 · FY2008 · HL · contact PI
RAAS, INFLAMMATION, AND POST-OPERATIVE AF$4,603
M01 · FY2008 · RR · contact PI
GENES AND FIBRINOLYTIC CAPACITY OF HUMAN ENDOTHELIUM$1,710
M01 · FY2008 · RR · contact PI
RAAS AND FIBRINOLYSIS: ACEI AND PE5I$433
M01 · FY2008 · RR · contact PI
BRADYKININ AND CORONARY ARTERY DISEASE IN DIALYSIS$410
M01 · FY2008 · RR · contact PI
BRADYKININ AND BLOOD PRESSURE RESPONSE TO RAMIPRIL$141
M01 · FY2008 · RR · contact PI
PHARMACOGENETICS OF ACE INHIBITOR-ASSOCIATED ANGIOEDEMA$23
M01 · FY2008 · RR · contact PI
BRADYKININ AND BLOOD PRESSURE RESPONSE TO LOSARTAN$12
M01 · FY2008 · RR · contact PI
RAAS, Inflammation & Post-Operative Atrial Fibrillation$578,215
R01 · FY2007 · HL · contact PI
Vanderbilt Environmental Health Science Scholars Program$489,281
K12 · FY2007 · ES · contact PI
Building Interdisciplinary Research Careers in Women's Health$476,877
K12 · FY2007 · HD · contact PI
Renin-Angiotensin and Fibrinolysis Interaction in Humans$393,947
R01 · FY2007 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$298,138
R01 · FY2007 · HL · contact PI
RAAS, INFLAMMATION, AND POST-OPERATIVE AF$97,716
M01 · FY2007 · RR · contact PI
GENES AND FIBRINOLYTIC CAPACITY OF HUMAN ENDOTHELIUM$36,300
M01 · FY2007 · RR · contact PI
RAAS AND FIBRINOLYSIS: ACEI AND PE5I$9,200
M01 · FY2007 · RR · contact PI
BRADYKININ AND CORONARY ARTERY DISEASE IN DIALYSIS$8,704
M01 · FY2007 · RR · contact PI
BRADYKININ AND BLOOD PRESSURE RESPONSE TO RAMIPRIL$2,983
M01 · FY2007 · RR · contact PI
PHARMACOGENETICS OF ACE INHIBITOR-ASSOCIATED ANGIOEDEMA$498
M01 · FY2007 · RR · contact PI
BRADYKININ AND BLOOD PRESSURE RESPONSE TO LOSARTAN$247
M01 · FY2007 · RR · contact PI
Vanderbilt Mentored Clinical Research Scholar Program$965,110
K12 · FY2006 · RR · contact PI
Building Interdisciplinary Research Careers in Women's *$492,802
K12 · FY2006 · HD · contact PI
RAAS, Inflammation & Post-Operative Atrial Fibrillation$485,321
R01 · FY2006 · HL · contact PI
Renin-Angiotensin and Fibrinolysis Interaction in Humans$401,747
R01 · FY2006 · HL · contact PI
Pharmacogenetics of ACE inhibitor-associated angioedema$306,157
R01 · FY2006 · HL · contact PI
Genes and Fibrinolytic Capacity of Human Endothelium$294,903
R01 · FY2006 · HL · contact PI
RAAS, INFLAMMATION, AND POST-OPERATIVE AF$65,438
M01 · FY2006 · RR · contact PI
RAAS, INFLAMMATION, AND POST-OPERATIVE AF-SA1$46,143
M01 · FY2006 · RR · contact PI
GENES AND FIBRINOLYTIC CAPACITY OF HUMAN ENDOTHELIUM$44,464
M01 · FY2006 · RR · contact PI
ANGIOTENSIN RECEPTOR BLOCKERS AND OXIDATIVE STRESS$34,397
M01 · FY2006 · RR · contact PI
BRADYKININ AND BLOOD PRESSURE RESPONSE TO RAMIPRIL$13,424
M01 · FY2006 · RR · contact PI
BRADYKININ AND BLOOD PRESSURE RESPONSE TO LOSARTAN$3,356
M01 · FY2006 · RR · contact PI
PHARMACOGENETICS OF ACE INHIBITOR-ASSOCIATED ANGIOEDEMA$839
M01 · FY2006 · RR · contact PI
Vanderbilt Mentored Clinical Research Scholar Program$1,286,833
K12 · FY2005 · RR
RAAS, Inflammation &Post-Operative Atrial Fibrillation$479,364
R01 · FY2005 · HL
PAI-1 and The Vascular Toxicity of Aldosterone$377,500
R01 · FY2005 · HL
Renin-angiotensin and fibrinolysis interaction in humans$377,500
R01 · FY2005 · HL
Pharmacogenetics of ACE inhibitor-associated angioedema$338,065
R01 · FY2005 · HL
Genes and Fibrinolytic Capacity of Human Endothelium$302,000
R01 · FY2005 · HL
BRADYKININ AND BLOOD PRESSURE RESPONSE TO RAMIPRIL$45,593
M01 · FY2005 · RR
RAAS, INFLAMMATION, AND POST-OPERATIVE AF-SA1$33,159
M01 · FY2005 · RR
GENES AND FIBRINOLYTIC CAPACITY OF HUMAN ENDOTHELIUM$29,935
M01 · FY2005 · RR
COMPARATIVE EFFECTS OF SPIRONOLACTONE VS TRIAMTERENE ON FIBRINOLYTIC BALANCE$24,409
M01 · FY2005 · RR
Vanderbilt Mentored Clinical Research Scholar Program$988,336
K12 · FY2004 · RR
Renin-angiotensin and fibrinolysis interaction in humans$377,500
R01 · FY2004 · HL
PAI-1 and The Vascular Toxicity of Aldosterone$377,500
R01 · FY2004 · HL
Genes and Fibrinolytic Capacity of Human Endothelium$302,000
R01 · FY2004 · HL
Bradykinin and Blood Pressure Response to Ramipril$99,585
M01 · FY2004 · RR
Comparative Effects of Spironolactone vs. Triamterene on Fibrinolytic Balance...$74,826
M01 · FY2004 · RR
Bradykinin and Blood Pressure Response to Losartan$16,506
M01 · FY2004 · RR
Genes and Fibrinolytic Capacity of Human Endothelium$15,405
M01 · FY2004 · RR
Vanderbilt Mentored Clinical Research Scholar Program$990,084
K12 · FY2003 · RR
PAI-1 and The Vascular Toxicity of Aldosterone$377,500
R01 · FY2003 · HL
Renin-angiotensin and fibrinolysis interaction in humans$339,750
R01 · FY2003 · HL
Genes and Fibrinolytic Capacity of Human Endothelium$302,000
R01 · FY2003 · HL
Vanderbilt Mentored Clinical Research Scholar Program$512,105
K12 · FY2002 · RR
PAI-1 and The Vascular Toxicity of Aldosterone$374,338
R01 · FY2002 · HL
Renin-angiotensin and fibrinolysis interaction in humans$339,750
R01 · FY2002 · HL
GENES AND FIBRINOLYTIC CAPACITY OF HUMAN ENDOTHELIUM$264,250
R01 · FY2002 · HL
SALT, HYPERTENSION/ RACE VASODILATOR BRADYKININ RESPONSE$0
M01 · FY2002 · RR
ANGIOTENSIN RECEPTOR ANTAGONISM WITH CANDESARTAN$0
M01 · FY2002 · RR
ROLE OF BRADYKININ IN REGULATION OF RENIN RELEASE$0
M01 · FY2002 · RR
ALDOSTERONE ANTAG ON FIBRINOLYTIC BALANCE IN HYPERTENSIO$0
M01 · FY2002 · RR
BRADYKININ 2 RECEPTOR EXPRESSION IN HYPERTENSION$0
M01 · FY2002 · RR
RELATIONSHIP BETWEEN ALDOSTERONE &FIBRINOLYTIC BALANCE$0
M01 · FY2002 · RR
RACIAL DIFFERENCES IN ACE ACTIVITY$0
M01 · FY2002 · RR
GENES AND FIBRINOLYTIC CAPACITY OF HUMAN ENDOTHELIUM$265,052
R01 · FY2001 · HL
ANGIOTENSIN RECEPTOR ANTAGONISM WITH CANDESARTAN$0
M01 · FY2001 · RR
ANGIOTENSIN RECEPTOR ANTAGONISM WITH CANDESARTAN$0
M01 · FY2001 · RR
ANGIOTENSIN RECEPTOR ANTAGONISM WITH CANDESARTAN$0
M01 · FY2001 · RR
ROLE OF BRADYKININ IN REGULATION OF RENIN RELEASE$0
M01 · FY2001 · RR
ROLE OF BRADYKININ IN REGULATION OF RENIN RELEASE$0
M01 · FY2001 · RR
ROLE OF BRADYKININ IN REGULATION OF RENIN RELEASE$0
M01 · FY2001 · RR
ALDOSTERONE ANTAG ON FIBRINOLYTIC BALANCE IN HYPERTENSIO$0
M01 · FY2001 · RR
ALDOSTERONE ANTAG ON FIBRINOLYTIC BALANCE IN HYPERTENSIO$0
M01 · FY2001 · RR
ALDOSTERONE ANTAG ON FIBRINOLYTIC BALANCE IN HYPERTENSIO$0
M01 · FY2001 · RR
SALT, HYPERTENSION/ RACE VASODILATOR BRADYKININ RESPONSE$0
M01 · FY2001 · RR
SALT, HYPERTENSION/ RACE VASODILATOR BRADYKININ RESPONSE$0
M01 · FY2001 · RR
SALT, HYPERTENSION/ RACE VASODILATOR BRADYKININ RESPONSE$0
M01 · FY2001 · RR
BRADYKININ 2 RECEPTOR EXPRESSION IN HYPERTENSION$0
M01 · FY2001 · RR
BRADYKININ 2 RECEPTOR EXPRESSION IN HYPERTENSION$0
M01 · FY2001 · RR
BRADYKININ 2 RECEPTOR EXPRESSION IN HYPERTENSION$0
M01 · FY2001 · RR
RELATIONSHIP BETWEEN ALDOSTERONE &FIBRINOLYTIC BALANCE$0
M01 · FY2001 · RR
RELATIONSHIP BETWEEN ALDOSTERONE &FIBRINOLYTIC BALANCE$0
M01 · FY2001 · RR
RELATIONSHIP BETWEEN ALDOSTERONE &FIBRINOLYTIC BALANCE$0
M01 · FY2001 · RR
RACIAL DIFFERENCES IN ACE ACTIVITY$0
M01 · FY2001 · RR
RACIAL DIFFERENCES IN ACE ACTIVITY$0
M01 · FY2001 · RR
RACIAL DIFFERENCES IN ACE ACTIVITY$0
M01 · FY2001 · RR
GENES AND FIBRINOLYTIC CAPACITY OF HUMAN ENDOTHELIUM$261,932
R01 · FY2000 · HL
RELATIONSHIP BETWEEN ALDOSTERONE &FIBRINOLYTIC BALANCE$592
M01 · FY2000 · RR
RACIAL DIFFERENCE IN RENAL HEMODYNAMIC RESPONSE TO ACE INHIBITORS$592
M01 · FY2000 · RR
RACIAL DIFFERENCES IN ACE ACTIVITY$0
M01 · FY2000 · RR
ANGIOTENSIN RECEPTOR ANTAGONISM WITH CANDESARTAN$0
M01 · FY2000 · RR
ROLE OF BRADYKININ IN REGULATION OF RENIN RELEASE$0
M01 · FY2000 · RR
ALDOSTERONE ANTAG ON FIBRINOLYTIC BALANCE IN HYPERTENSIO$0
M01 · FY2000 · RR
SALT, HYPERTENSION/ RACE VASODILATOR BRADYKININ RESPONSE$0
M01 · FY2000 · RR
BRADYKININ 2 RECEPTOR EXPRESSION IN HYPERTENSION$0
M01 · FY2000 · RR